Fujita, K.;                     Mimura, S.;                     Iwama, H.;                     Nakahara, M.;                     Oura, K.;                     Tadokoro, T.;                     Nomura, T.;                     Tani, J.;                     Yoneyama, H.;                     Morishita, A.;     
    et al.    Serum miRNAs Predicting Sustained HBs Antigen Reduction 48 Weeks after Pegylated Interferon Therapy in HBe Antigen-Negative Patients. Int. J. Mol. Sci. 2018, 19, 1940.
    https://doi.org/10.3390/ijms19071940
    AMA Style
    
                                Fujita K,                                 Mimura S,                                 Iwama H,                                 Nakahara M,                                 Oura K,                                 Tadokoro T,                                 Nomura T,                                 Tani J,                                 Yoneyama H,                                 Morishita A,         
        et al.        Serum miRNAs Predicting Sustained HBs Antigen Reduction 48 Weeks after Pegylated Interferon Therapy in HBe Antigen-Negative Patients. International Journal of Molecular Sciences. 2018; 19(7):1940.
        https://doi.org/10.3390/ijms19071940
    
    Chicago/Turabian Style
    
                                Fujita, Koji,                                 Shima Mimura,                                 Hisakazu Iwama,                                 Mai Nakahara,                                 Kyoko Oura,                                 Tomoko Tadokoro,                                 Takako Nomura,                                 Joji Tani,                                 Hirohito Yoneyama,                                 Asahiro Morishita,         
         and et al.        2018. "Serum miRNAs Predicting Sustained HBs Antigen Reduction 48 Weeks after Pegylated Interferon Therapy in HBe Antigen-Negative Patients" International Journal of Molecular Sciences 19, no. 7: 1940.
        https://doi.org/10.3390/ijms19071940
    
    APA Style
    
                                Fujita, K.,                                 Mimura, S.,                                 Iwama, H.,                                 Nakahara, M.,                                 Oura, K.,                                 Tadokoro, T.,                                 Nomura, T.,                                 Tani, J.,                                 Yoneyama, H.,                                 Morishita, A.,                                 Oryu, M.,                                 Himoto, T.,                                 Nishitsuji, H.,                                 Shimotohno, K.,                                 Omata, M.,                                 & Masaki, T.        
        
        (2018). Serum miRNAs Predicting Sustained HBs Antigen Reduction 48 Weeks after Pegylated Interferon Therapy in HBe Antigen-Negative Patients. International Journal of Molecular Sciences, 19(7), 1940.
        https://doi.org/10.3390/ijms19071940